There`s a reason they`re called Pressure Ulcers.

for pressure ulcers
Heal me soon or
costs may skyrocket!
Heal me early or
I may stick around longer!
Heal me now or Heal me now or
I may have to be readmitted!
I may have to be readmitted!
There’s a reason they’re called Pressure Ulcers.
V.A.C.® Therapy: Demonstrated effective at healing
pressure ulcers and reducing pressure on you.1,2
Understanding the Pressure From Pressure Ulcers.
Advanced pressure ulcers (Stage III or IV) are a common problem, both in hospitals and post-acute settings. In fact, an
estimated 2.5 million patients will have a pressure ulcer this year in acute care alone.3 And that’s when the pressure really
starts to build in any care setting:
Treatment costs for a Stage III or IV pressure ulcer can range up to $70,000 per patient3
• A
cute Care: Facility-acquired
­pressure ulcers are no longer
­reimbursed by CMS
–A
s of October 1, 2008, CMS no longer
assigned a DRG for facility-­acquired
pressure ulcers as a secondary diagnosis4
– In 2007, there were 257,000 cases of
hospital-acquired p
­ ressure ulcers, with an
average treatment cost of $43,0004
• L ong-term Care: In 2004, CMS
released the revised Federal
Regulation for pressure ulcers
(F-314)
• H
ome Care: CMS and other quality
initiatives are shifting the focus from cost
to quality of care1
–A
llows state surveyors to determine
appropriate prevention and treatment for
patients in long-term care facilities3
– F -314 allows surveyors to quickly and
definitively impose fines and withhold
federal reimbursement for failure to
implement and document evidence-based
practices for pressure ulcers3
Negative Pressure,
Positive Outcomes.
V.A.C.® Therapy has been demonstrated to be
effective at healing advanced pressure ulcers.1,2
So you can address your patients’ care and
your institution’s well-being all at once.
–W
ounds must now show a progression for healing
within a brief, specified time period
– E videnced-based treatment options for prevention
and early intervention are stressed now more
than ever
–U
se of Outcomes and Assessment Information Set
(Oasis C) will help track performance indicators for
home health agencies; pressure ulcer assessment
and management is a component of Oasis C
Rehospitalization due to wound problems*
5%
V.A.C.® Therapy Group (n=60)
Control Group (n=2,268)
14%
0%
A retrospective study was conducted
to determine the prevalence of Stage III and
Stage IV pressure ulcers in the home health
population and to quantify the impact of
V.A.C.® Therapy (n=60) vs. patients not
receiving V.A.C.® Therapy (n=2,268). This study
showed V.A.C.® Therapy had an impact in
reducing acute care rehospitalizations
(5% vs. 14%, P<.01) and emergent care
needed (0% vs. 8%, P<.01) for wound
problems when compared to the control
group.1,2
2%
4%
6%
8% 10% 12% 14% 16%
Emergent care required due to wound problems*
V.A.C.® Therapy Group (n=60)
0%
Control Group (n=2,268)
8%
0%
2%
4%
6%
8%
10%
*Wound problems related to deteriorating wound status or infection.
Act Early, Heal Early.
Early intervention of V.A.C.® Therapy
may be associated with shorter
lengths of stay for Stage III and Stage IV
pressure ulcer patients.
Pressure Ulcers
180
160
140
120
Mean Length of Stay (days)
In a retrospective study of home care
patients using Oasis C data, early
initiation of V.A.C.® Therapy (within
30 days of starting home health care,
n=65) resulted in a 48% overall
reduction (P≤ .0001) in home care length
of stay in patients with a Stage III or
IV pressure ulcer vs. the group who
received V.A.C.® Therapy after the
31st day of home health care.2
Early Initiation of V.A.C. ® Therapy
48%
Reduction
166
n=33
100
80
60
40
85
n=65
20
Early V.A.C.® Therapy Placement
(within the first 30 days)
Late V.A.C.® Therapy Placement (after the 31 day)
Sacral Pressure Ulcer
Case Study
This 84-year-old female was treated
for a Stage III sacral pressure ulcer.
This admission was complicated by
the development of a urinary tract
infection and dehydration.
Before V.A.C.® Therapy
The wound had been present for 6
months and had been treated with
wet-to-dry saline gauze before
V.A.C.® Therapy was applied.
V.A.C.® Therapy, Day 2
The second photo shows continued
improvement of the wound following
2 days of V.A.C.® Therapy.
As with any case study, the results and
outcomes should not be interpreted as a
guarantee or warranty of similar results.
Individual results may vary depending on
the patient’s circumstances and condition.
V.A.C.® Therapy, Day 13
The third photo shows continued
improvement of the wound following
13 days of V.A.C.® Therapy.
V.A.C.® GranuFoam™ Bridge XG Dressing —
Simple Application, Proven Healing.
Designed for the busy clinician to simplify
dressing application while still providing all the
outcomes associated with V.A.C.® Therapy.
V.A.C.® GranuFoam™ Bridge XG Dressing offers:
•A
n integrated, pre-made bridge to allow the
SensaT.R.A.C.™ Pad to be placed away from
the wound site to reduce pressure points
•A
moisture-wicking layer to help intact skin
remain dry and prevent maceration
• S piral-shaped V.A.C.® GranuFoam™ that is
simple to size to the wound bed and provides
easy customization without cutting
• P erforated V.A.C.® Drape to provide potential
time savings with dressing application
ORDERING INFORMATION
KCI Order Number
Product
M8275044/5.S
V.A.C.® GranuFoam™ Bridge XG Dressing, 5-pack
CMS requires use of a pressure reduction surface
for patients with Stage III and IV pressure ulcers.
For more information on how V.A.C.® Therapy can help you treat and heal
advanced pressure ulcers, or on the V.A.C.® GranuFoam™ Bridge XG Dressing,
call 1-800-275-4524 or visit www.kci1.com
References
1. S chwien T, Gilbert J, Lang C. Pressure ulcer prevalence and the role of negative pressure wound therapy in home health quality outcomes.
Ostomy Wound Management. 2005 Sep;51(9):47-60.
2. Baharestani MM, Houliston-Otto DB, Barnes S. Early versus late initiation of negative pressure wound therapy: examining the impact on home care
length of stay. Ostomy Wound Management. 2008;54(11):48-53.
3. Baharestani MM, de Leon J, Mendez-Eastman S, et al. Consensus Statement: A practical guide for managing pressure ulcers with negative pressure
wound therapy utilizing vacuum-assisted closure—understanding the treatment algorithm. Advances in Skin and Wound Care. 2008;21(Suppl1):1-20.
4. Armstrong DG, Ayello EA, Capitulo KL, et al. Opportunities to improve pressure ulcer prevention and treatment: Implications of the CMS inpatient
hospital care Present on Admission (POA) Indicators/Hospital-Acquired Conditions (HAC) policy. Wounds. 2008;20(9):A14-A26.
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for the V.A.C.® Therapy System.
Please consult a physician and product instructions for use prior to application. Rx only.
Caution: Federal Law restricts this device to sales by or on the order of a physician.
© 2010 KCI Licensing, Inc. All Rights Reserved. All trademarks designated
herein are proprietary to KCI Licensing, Inc, its affiliates and/or licensors.
DSL#13-0068.US • LIT#29-A-207 • (2/13)